Search Within

Dilara Akbulut

Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Sloan Kettering Institute Postdocs (6)
  2. Department of Pathology and Laboratory Medicine (3)
  3. GME, Pathology (3)
  4. Graduate Medical Education (3)
  5. Department of Medicine (2)
  6. Genitourinary Oncology Service (2)

More Groups

People
  1. Anuradha Gopalan (3)
  2. Gamze Gokturk Ozcan (3)
  3. Hikmat Al-Ahmadie (3)
  4. Jie-Fu Chen (3)
  5. Judy Sarungbam (3)
  6. Marina Baine (3)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (2)
Publications
  1. Modern Pathology (3)
  2. Laboratory Investigation (2)
  3. Journal of Clinical Oncology (1)
Publishers
  1. Nature Research (3)
  2. Nature Publishing Group (2)
  3. American Society of Clinical Oncology (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell/neuroendocrine carcinoma with prognostic implications
    Journal Article

    Akbulut, D.; Whiting, K.; Teo, M. Y.; Tallman, J. E.; Ozcan, G. G.; Basar, M.; Jia, L.; Rammal, R.; Chen, J. F.; Sarungbam, J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Mismatch repair deficiency and microsatellite instability-high in urothelial carcinoma: A systematic review and meta-analysis
    Meeting Abstract

    Chandran, E.; Iannantuono, G. M.; Akbulut, D.; Atiq, S. O.; Gurram, S.; Teo, M. Y.; Coleman, J.; Sinaii, N.; Apolo, A. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Comprehensive profiling of neuroendocrine carcinomas of the bladder with expanded neuroendocrine markers ASCL1, NEUROD1, POU2F3, YAP1 and DLL3
    Meeting Abstract

    Akbulut, D.; Jia, L.; Gokturk Ozcan, G.; Gandhi, J.; Rammal, R.; Chen, J. F.; Sarungbam, J.; Xu, B.; Sirintrapun, S. J.; Fine, S.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Comprehensive profiling of neuroendocrine carcinomas of the bladder with expanded neuroendocrine markers ASCL1, NEUROD1, POU2F3, YAP1 and DLL3
    Meeting Abstract

    Akbulut, D.; Jia, L.; Ozcan, G. G.; Gandhi, J.; Rammal, R.; Chen, J. F.; Sarungbam, J.; Xu, B.; Sirintrapun, S. J.; Fine, S.; more...
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Immune checkpoint molecule (PD-1, PD-L1, PD-L2) expression, 9p24.1 gene locus alterations and tumor microenvironment status of primary central nervous system lymphoma and their clinical relevance: A quantitative analysis
    Meeting Abstract

    Akbulut, D.; Yuksel, S.; Kircali, E.; Aktas, B. Y.; Kaygusuz, G.; Saglam, A.; Soylemezoglu, F.; Uner, A.; Ozcan, M.; Turker, A.; more...
    Modern Pathology (2021)

    Fulltext@MSK | Save
  • Immune checkpoint molecule (PD-1, PD-L1, PD-L2) expression, 9p24.1 gene locus alterations and tumor microenvironment status of primary central nervous system lymphoma and their clinical relevance: A quantitative analysis
    Meeting Abstract

    Akbulut, D.; Yuksel, S.; Kircali, E.; Aktas, B. Y.; Kaygusuz, G.; Saglam, A.; Soylemezoglu, F.; Uner, A.; Ozcan, M.; Turker, A.; more...
    Laboratory Investigation (2021)

    Fulltext@MSK | Save